Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Elliott Sigal
|
| gptkbp:developedBy |
therapeutics for Alzheimer's disease
therapeutics for Parkinson's disease therapeutics for systemic amyloidosis |
| gptkbp:focusesOn |
neurodegenerative diseases
protein misfolding diseases |
| gptkbp:formerName |
gptkb:NeuroPhage_Pharmaceuticals
|
| gptkbp:foundedYear |
2007
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts
|
| gptkbp:platform |
GAIM (General Amyloid Interaction Motif)
|
| gptkbp:website |
https://www.proclarabio.com/
|
| gptkbp:bfsParent |
gptkb:Neurophage_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Proclara Biosciences
|